JCVI Statement on Herpes zoster vaccines - 31 January 2010

Based on the evidence, the UK Joint Committee on Vaccination and Immunisation (JCVI) recommended that a universal herpes zoster vaccination programme for adults aged 70 up to and including 79 years should be introduced provided that a licensed vaccine is available at a cost effective price. Source: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_111689.pdf